Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT05585034What this trial is testingPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more Xencor, Inc. 60
Early research (Phase 1)Ended earlyNCT01212887What this trial is testingTreated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With CancerWho this might be right forBreast CancerColorectal CancerGastric Cancer+4 more Cancer Research UK 14
Large-scale testing (Phase 3)Study completedNCT00782145What this trial is testingA Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their FamiliesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more Tufts Medical Center 198
Testing effectiveness (Phase 2)UnknownNCT00772798What this trial is testingA Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian CancerWho this might be right forOvarian Cancer Herlev Hospital 70
Early research (Phase 1)Study completedNCT00060372What this trial is testingIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more National Cancer Institute (NCI) 21
Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Testing effectiveness (Phase 2)Study completedNCT00003072What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerWho this might be right forLung CancerNeurotoxicityOvarian Cancer University of California, San Francisco 80
Testing effectiveness (Phase 2)Looking for participantsNCT06953089What this trial is testingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumors DualityBio Inc. 492
Early research (Phase 1)Looking for participantsNCT06756035What this trial is testingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionWho this might be right forMesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more Context Therapeutics Inc. 70
Not applicableWithdrawnNCT01558778What this trial is testingMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more Roswell Park Cancer Institute
Large-scale testing (Phase 3)Active Not RecruitingNCT03815643What this trial is testingAvelumab Program Rollover StudyWho this might be right forSolid Tumors EMD Serono Research & Development Institute, Inc. 205
Testing effectiveness (Phase 2)Study completedNCT02983799What this trial is testingOlaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor StatusWho this might be right forRelapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity AstraZeneca 272
Early research (Phase 1)Active Not RecruitingNCT06607185What this trial is testingThe Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more Eli Lilly and Company 750
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Not applicableWithdrawnNCT04889495What this trial is testingA Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWho this might be right forNon-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more Pfizer
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Early research (Phase 1)UnknownNCT03076372What this trial is testingA Study Evaluating MM-310 in Patients With Solid TumorsWho this might be right forSolid TumorsUrothelial CarcinomaGastric Carcinoma+9 more Merrimack Pharmaceuticals 34
Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic